Results 131 to 140 of about 11,145 (294)
CLINICAL ASSESSMENT IN PSORIATIC ARTHRITIS
Due to the heterogenous clinical picture, with a possible combination in any individual patient of axial disease, peripheral arthritis, enthesitis and dactylitis, psoriatic arthritis (PsA) is difficult to assess.
M.G. Catanoso, N. Pipitone, C. Salvarani
doaj +1 more source
Objective. To use ultrasonography to study whether the duration of psoriatic dactylitis was associated with different patterns of extracapsular and synovial-based involvement. Methods.
N. Girolimetto +13 more
semanticscholar +1 more source
Tuberculous dactylitis is a distinctly uncommon, yet well recognized form of tuberculosis involving the small bones of the hand or foot. It occurs in young children in endemic areas under 5 years of age.
Bhaskar, Tashi Khonglah, Jerryson Bareh
doaj +1 more source
SAT0356 DACTYLITIS IN EARLY SPONDYLOARTHRITIS. DATA FROM THE DESIR COHORT [PDF]
Daniel Wendling +6 more
openalex +1 more source
An unusual presentation of tubercular dactylitis with subluxation of the metacarpo-phalangeal joint in an adult [PDF]
Arunodhaya Siddartha +3 more
openalex +1 more source
Bisphosphonates: Ally or Enemy in the Fight Against Rheumatological Diseases? Two Case Report
Due to their primary and well-known antiresorptive activity, bisphosphonate (BPs) are commonly prescribed as first-line drugs for osteoporosis treatment.
Sibel Süzen Özbayrak +4 more
doaj +1 more source
Background: Systemic inflammation in psoriatic arthritis (PsA) is linked to cardiometabolic comorbidities like hypertension, diabetes, dyslipidaemia, and coronary artery disease (CAD), affecting disease management and outcomes.
Illiasul Ibad +3 more
doaj +1 more source
POS1058 SUBCLINICAL DACTYLITIS: COMPARATIVE STUDY OF THERAPEUTIC RESPONSE WITH TNF INHIBITORS, SECUKINUMAB AND USTEKINUMAB [PDF]
Carlos Antonio Guillén Astete +2 more
openalex +1 more source
BioRePortAP, an electronic clinical record coupled with a database : an example of its use in a single [PDF]
Aims: To evaluate the efficacy and safety of the treatment of psoriatic arthritis (PsA) patients with tumor necrosis factor (TNF) antagonists in the Rheumatology Department of Hospital de Santa Maria using the BioRePortAP.
Campanilho-Marques, R. +9 more
core

